Suppr超能文献

在急诊科应用单次高敏心肌肌钙蛋白 T 快速排除急性心肌损伤和梗死:一项多中心美国评估。

Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation.

机构信息

Department of Cardiovascular Diseases (Y.L., L.D.M., R.L., R.G., A.S.J.), Mayo Clinic, Rochester, MN.

Division of Biomedical Statistics and Informatics (B.R.L.), Mayo Clinic, Rochester, MN.

出版信息

Circulation. 2022 Jun 7;145(23):1708-1719. doi: 10.1161/CIRCULATIONAHA.122.059235. Epub 2022 May 10.

Abstract

BACKGROUND

There are good data to support using a single high-sensitivity cardiac troponin T (hs-cTnT) below the limit of detection of 5 ng/L to exclude acute myocardial infarction. Per the US Food and Drug Administration, hs-cTnT can only report to the limit of quantitation of 6 ng/L, a threshold for which there are limited data. Our goal was to determine whether a single hs-cTnT below the limit of quantitation of 6 ng/L is a safe strategy to identify patients at low risk for acute myocardial injury and infarction.

METHODS

The efficacy (proportion identified as low risk based on baseline hs-cTnT<6 ng/L) of identifying low-risk patients was examined in a multicenter (n=22 sites) US cohort study of emergency department patients undergoing at least 1 hs-cTnT (CV Data Mart Biomarker cohort). We then determined the performance of a single hs-cTnT<6 ng/L (biomarker alone) to exclude acute myocardial injury (subsequent hs-cTnT >99th percentile in those with an initial hs-cTnT<6 ng/L). The clinically intended rule-out strategy combining a nonischemic ECG with a baseline hs-cTnT<6 ng/L was subsequently tested in an adjudicated cohort in which the diagnostic performance for ruling out acute myocardial infarction and safety (myocardial infarction or death at 30 days) were evaluated.

RESULTS

A total of 85 610 patients were evaluated in the CV Data Mart Biomarker cohort, among which 24 646 (29%) had a baseline hs-cTnT<6 ng/L. Women were more likely than men to have hs-cTnT<6 ng/L (38% versus 20%, <0.0001). Among 11 962 patients with baseline hs-cTnT<6 ng/L and serial measurements, only 1.2% developed acute myocardial injury, resulting in a negative predictive value of 98.8% (95% CI, 98.6-99.0) and sensitivity of 99.6% (95% CI, 99.5-99.6). In the adjudicated cohort, a nonischemic ECG with hs-cTnT<6 ng/L identified 33% of patients (610/1849) as low risk and resulted in a negative predictive value and sensitivity of 100% and a 30-day rate of 0.2% for myocardial infarction or death.

CONCLUSIONS

A single hs-cTnT below the limit of quantitation of 6 ng/L is a safe and rapid method to identify a substantial number of patients at very low risk for acute myocardial injury and infarction.

摘要

背景

有充分的数据支持使用单个高敏肌钙蛋白 T(hs-cTnT)低于检测限 5ng/L 来排除急性心肌梗死。根据美国食品和药物管理局的规定,hs-cTnT 只能报告至 6ng/L 的定量限,这一阈值的数据有限。我们的目标是确定 hs-cTnT 低于 6ng/L 的定量限是否是一种安全的策略,可以识别急性心肌损伤和梗死风险较低的患者。

方法

在一项多中心(22 个地点)美国急诊科患者进行至少 1 次 hs-cTnT(CV Data Mart Biomarker 队列)的研究中,我们检测了基于基线 hs-cTnT<6ng/L 识别低危患者的功效(根据基线 hs-cTnT<6ng/L 确定为低危的患者比例)。然后,我们确定了单个 hs-cTnT<6ng/L(仅生物标志物)排除急性心肌损伤的性能(在初始 hs-cTnT<6ng/L 的患者中,随后的 hs-cTnT>99 百分位)。随后,在一个经过裁决的队列中测试了结合非缺血性心电图和基线 hs-cTnT<6ng/L 的临床预期排除策略,评估了排除急性心肌梗死的诊断性能和安全性(30 天内心肌梗死或死亡)。

结果

在 CV Data Mart Biomarker 队列中评估了 85610 例患者,其中 24646 例(29%)基线 hs-cTnT<6ng/L。女性比男性更有可能 hs-cTnT<6ng/L(38%比 20%,<0.0001)。在 11962 例基线 hs-cTnT<6ng/L 且有连续测量值的患者中,仅有 1.2%发生急性心肌损伤,阴性预测值为 98.8%(95%CI,98.6-99.0),敏感性为 99.6%(95%CI,99.5-99.6)。在裁决队列中,非缺血性心电图结合 hs-cTnT<6ng/L 确定了 33%的患者(610/1849)为低危,阴性预测值和敏感性为 100%,30 天内心肌梗死或死亡发生率为 0.2%。

结论

hs-cTnT 低于 6ng/L 的定量限是一种安全、快速的方法,可以识别出大量急性心肌损伤和梗死风险极低的患者。

相似文献

8
Clinical impact of the 2010-2012 low-end shift of high-sensitivity cardiac troponin T.2010 - 2012年高敏肌钙蛋白T低值偏移的临床影响
Eur Heart J Acute Cardiovasc Care. 2016 Oct;5(6):399-408. doi: 10.1177/2048872616642952. Epub 2016 Apr 7.

引用本文的文献

6
High-Sensitivity Troponin: Finding a Meaningful Delta.高敏肌钙蛋白:寻找有意义的变化值
J Cardiovasc Dev Dis. 2024 Oct 11;11(10):318. doi: 10.3390/jcdd11100318.

本文引用的文献

5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验